Original Articles

High seroprevalence and associated risk factors of visceral leishmaniasis in the Léré Health District, Chad

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 18 December 2025
147
Views
46
Downloads
11
HTML

Authors

Visceral leishmaniasis (VL) is a major neglected tropical disease in Chad, particularly in the Léré Health District, where epidemiological data remain scarce. This study aimed to determine the seroprevalence of VL among symptomatic patients and to identify associated sociodemographic, behavioral, and environmental risk factors. A cross-sectional study was conducted from July to October 2022 among patients presenting symptoms suggestive of VL. After obtaining informed consent, participants completed a structured questionnaire capturing demographic, environmental, and behavioral characteristics. Blood samples were collected and analyzed using a rapid diagnostic test (RDT) for VL. Data analysis was performed using XLSTAT software. Among the 303 patients, the seroprevalence of VL was 37.62%. Women represented 55% of participants, and children aged 0-14 years constituted the most affected age group (38.28%). Significant associations were observed between VL positivity and rural residence, low education level, limited knowledge about VL, proximity to forested areas, presence of domestic animals, particularly dogs, and inadequate vector-control practices. VL remains a major public health concern in the Léré district. Transmission is driven by a combination of environmental factors, socio-economic vulnerability, and the presence of zoonotic reservoirs. Urgent action is required to strengthen disease surveillance, expand access to reliable diagnostic services, enhance community awareness, and implement integrated One Health interventions to reduce transmission and protect vulnerable populations.

Downloads

Download data is not yet available.

Citations

Dedet JP, Carme B, Desbois N, et al. Epidemiology of autochthonous leishmaniases in France. Presse Med 2013;42:1469-81. DOI: https://doi.org/10.1016/j.lpm.2013.03.010
Mouloua A, Boubidi SC, Bouiba L, et al. [Environmental Impact on the Distribution of Leishmaniasis in the Tizi-Ouzou Focus (Algeria)]. Rev Med Vet 2017;168:252-61.
Jain S, Madjou S, Virrey Agua JF, et al. Global leishmaniasis surveillance 2019-2020: a baseline for the 2030 roadmap. PLoS Negl Trop Dis. 2021;15:e0009852
World Health Organization. Neglected tropical diseases. Geneva: WHO; 2013 [cited 2025 May 20]. Available from: https://policycommons.net/artifacts/462855/maladies-tropicales-negligees/1435955/
Desjeux P. Information on the epidemiology and control of the leishmaniases by country or territory. Geneva: World Health Organization; 1991 [cited 2025 May 20]. Available from: https://pesquisa.bvsalud.org/portal/resource/pt/who-62132
Mad-Toïngué J, Ahmat MA, Djarma OM, et al. Visceral leishmaniasis at the National Reference University Hospital Center of N’Djamena (Chad): epidemiological, clinical, diagnostic, therapeutic and prognostic aspects. Adv Infect Dis 2024;14:478-86. DOI: https://doi.org/10.4236/aid.2024.142034
World Health Organization. Leishmaniasis: key facts [Internet]. Geneva: WHO; 2023 [cited 2025 May 27]. Available from: https://www.who.int/fr/news-room/fact-sheets/detail/leishmaniasis
World Health Organization Regional Office for Africa. WHO supports Chad in its fight against a deadly neglected tropical disease: visceral leishmaniasis [Internet]. Brazzaville: WHO AFRO; 2023 [cited 2025 May 27]. Available from: https://www.afro.who.int/fr/news/loms-appuie-le-tchad-dans-ses-efforts-lutter-contre-une-maladie-tropicale-negligee-mortelle-la
Bougar H, Chachoua M, Hassani M. [Epidemiological Study on Leishmaniasis in Aïn Defla]. Université Khemis Miliana; 2022. Available from: http://dspace.univ-km.dz/xmlui/handle/123456789/5685
Aoun K, Jeddi F, Amri F, et al. Current epidemiological data on visceral leishmaniasis in Tunisia. Med Mal Infect 2009;39:775-9. DOI: https://doi.org/10.1016/j.medmal.2009.08.010
Fendri AH, Beldjoudi W, Ahraou S, Djaballah M. [Leishmaniasis in Constantine (Algeria): Review of five years (2006–2010) at the University Hospital]. Bull Soc Pathol Exot 2012;105:46-8. DOI: https://doi.org/10.1007/s13149-011-0203-z
Nunes BEBR, Leal TC, Paiva JPS, et al. Social determinants of mortality due to visceral leishmaniasis in Brazil, 2001-2015: an ecological study. Rev Soc Bras Med Trop 2019;53:e20190262 DOI: https://doi.org/10.1590/0037-8682-0262-2019
World Health Organization. Integrating neglected tropical diseases in global health and development: Fourth WHO report on neglected tropical diseases. Geneva: WHO; 2017 [cited 2025 May 27]. Available from: https://www.who.int/publications/i/item/9789241565448
Demba Kodindo I, Gonnonta V, Muller G, et al. Retrospective Study of Visceral Leishmaniasis in the Health District of Léré in Chad, Central Africa. Preprint [Internet]. Research Square; 2023. Available from: https://doi.org/10.21203/rs.3.rs-401673/v1 DOI: https://doi.org/10.21203/rs.3.rs-401673/v1
Rhajaoui M. Human leishmaniases in Morocco: a nosogeographical diversity. Pathol Biol (Paris) 2011;59:226-9. DOI: https://doi.org/10.1016/j.patbio.2009.09.003
Abazid N, Jones C, Davies CR. Knowledge, attitudes and practices about leishmaniasis among cutaneous leishmaniasis patients in Aleppo, Syrian Arab Republic. East Mediterr Health J 2012;18:7. DOI: https://doi.org/10.26719/2012.18.1.7
Institut de Recherche pour le Développement. [Personal protection against vectors: insecticide-treated nets]. Marseille: IRD Éditions; 2011 [cited 2025 May 27].Available from: https://books.openedition.org/irdeditions/9387?lang=fr
Noubaramadji Yamti Suitombaye, Laboratoire des Grandes Épidémies Tropicales, University Hospital Complex “Le Bon Samaritain”, N’Djamena

Doctoral School of Advanced Sciences for Sustainable Development of the Evangelical University of Cameroon, Bandjoun, Cameroon.

Abel Dafogo Djibagaou, Faculty of Medicine, University Hospital Complex “Le Bon Samaritain”, N’Djamena; Laboratoire des Grandes Épidémies Tropicales, University Hospital Complex “Le Bon Samaritain”, N’Djamena

Doctoral School of Advanced Sciences for Sustainable Development of the Evangelical University of Cameroon, Bandjoun, Cameroon.

Amine Akouya, Laboratoire des Grandes Épidémies Tropicales, University Hospital Complex “Le Bon Samaritain”, N’Djamena

Doctoral School of Advanced Sciences for Sustainable Development of the Evangelical University of Cameroon, Bandjoun, Cameroon.

Koutaya Dezoumbe, Faculty of Medicine, University Hospital Complex “Le Bon Samaritain”, N’Djamena; Laboratoire des Grandes Épidémies Tropicales, University Hospital Complex “Le Bon Samaritain”, N’Djamena

Doctoral School of Advanced Sciences for Sustainable Development of the Evangelical University of Cameroon, Bandjoun, Cameroon.

How to Cite



High seroprevalence and associated risk factors of visceral leishmaniasis in the Léré Health District, Chad. (2025). Sahelian Journal of Responsible One Health, 1(3). https://doi.org/10.4081/sjroh.2025.602